Results for tag: "Belotecan"

Belotecan is a type of oncology drug used to treat certain types of cancer. It is a topoisomerase I inhibitor, meaning it works by blocking the enzyme topoisomerase I, which is involved in the replication of cancer cells. Belotecan is used to treat small cell lung cancer, ovarian cancer, and other types of cancer. It is typically administered intravenously and is available in both generic and brand-name formulations. The Belotecan market is a rapidly growing segment of the oncology drug market. It is driven by the increasing prevalence of cancer, as well as the development of new and more effective treatments. Belotecan is a relatively new drug, but it has already shown promise in treating certain types of cancer. Some of the major companies in the Belotecan market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, and Pfizer. These companies are all involved in the development and marketing of Belotecan and other oncology drugs. Show Less Read more